CMS’s 2015 ACO Performance Data Confirms: Newer ACO Models Are More Attractive
Learn about the different tracks and why we think MSSP Track 3 and Next Generation ACO promise much higher returns than Track 1.
Nico Lewine is Evolent Health's Managing Director of Clinical Research and Development. Nico has served many of Evolent’s partners in developing system-level strategies, with particular focus on Medicare programs such as Next Generation ACO, MSSP, CPC+, and more. Prior to joining Evolent in early 2014, Nico was an Engagement Manager at a boutique healthcare consultancy in Boston. He received his BA in Molecular & Cellular Biology from Harvard University.